AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Description

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

D-FW biotech firm completes “first ever” AI clinical trial

Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Antibody Engineering, Antibody Therapeutics

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

Branded Content Archives · TechNode

EISAI PRESENTS FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER'S DISEASE AT CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE - Nov 29, 2022

TCER® IMA402

TCDI Announces Strategic Partnership with Altumatim to Elevate AI-Powered Document Review and Data Intelligence

Insilico Medicine achieves AI drug discovery breakthrough

TechNode

Undetectable AI Free tool

Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Anthropic “Claude 3” Models: AI That's Faster, Smarter, and Challenges ChatGPT-4, by AI TutorMaster, Mar, 2024

New Clinical Trial Focuses on Targeted Alpha-Emitter Therapy of PRRT - NETRF

$ 15.99USD
Score 4.8(624)
In stock
Continue to book